# OnCo record ifm-2009 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/ifm-2009/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "ifm-2009", "NCT01191060" ;
  schema:name "IFM 2009"@en ;
  schema:alternateName "IFM/DFCI 2009"@en, "IFM 2009 trial"@en ;
  schema:description "IFM 2009 asked whether a stem cell transplant is still needed when myeloma is treated with modern three-drug therapy; the transplant kept the disease away for longer, though patients lived about as long either way because those who relapsed could be transplanted later."@en ;
  schema:url <https://onco.cc/trials/ifm-2009/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01191060> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/myeloma-transplant-eligible/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:drugs <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/dexamethasone/> ;
  onco:people <https://onco.cc/people/michel-attal/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ifm-2009-attal-nejm-2017/> .